Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option

Alessandra Iurlo, Daniele Cattaneo, Nicola Orofino, Cristina Bucelli, Matteo Molica, Massimo Breccia

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)475-476
Number of pages2
JournalClinical Drug Investigation
Volume38
Issue number5
DOIs
Publication statusPublished - 2018

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients : A Safe and Effective Option. / Iurlo, Alessandra; Cattaneo, Daniele; Orofino, Nicola; Bucelli, Cristina; Molica, Matteo; Breccia, Massimo.

In: Clinical Drug Investigation, Vol. 38, No. 5, 2018, p. 475-476.

Research output: Contribution to journalArticle

Iurlo, Alessandra ; Cattaneo, Daniele ; Orofino, Nicola ; Bucelli, Cristina ; Molica, Matteo ; Breccia, Massimo. / Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients : A Safe and Effective Option. In: Clinical Drug Investigation. 2018 ; Vol. 38, No. 5. pp. 475-476.
@article{b07eeedd6c144f22984400e666384706,
title = "Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option",
author = "Alessandra Iurlo and Daniele Cattaneo and Nicola Orofino and Cristina Bucelli and Matteo Molica and Massimo Breccia",
year = "2018",
doi = "10.1007/s40261-018-0623-7",
language = "English",
volume = "38",
pages = "475--476",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "5",

}

TY - JOUR

T1 - Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients

T2 - A Safe and Effective Option

AU - Iurlo, Alessandra

AU - Cattaneo, Daniele

AU - Orofino, Nicola

AU - Bucelli, Cristina

AU - Molica, Matteo

AU - Breccia, Massimo

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85040860195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040860195&partnerID=8YFLogxK

U2 - 10.1007/s40261-018-0623-7

DO - 10.1007/s40261-018-0623-7

M3 - Article

AN - SCOPUS:85040860195

VL - 38

SP - 475

EP - 476

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 5

ER -